KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Adaptive Biotechnologies (ADPT) Return on Equity (2019 - 2025)

Adaptive Biotechnologies (ADPT) has disclosed Return on Equity for 7 consecutive years, with 0.28% as the latest value for Q4 2025.

  • Quarterly Return on Equity rose 47.0% to 0.28% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 0.28% through Dec 2025, up 47.0% year-over-year, with the annual reading at 0.28% for FY2025, 34.0% up from the prior year.
  • Return on Equity hit 0.28% in Q4 2025 for Adaptive Biotechnologies, up from 0.41% in the prior quarter.
  • In the past five years, Return on Equity ranged from a high of 0.21% in Q1 2021 to a low of 0.84% in Q3 2024.
  • Historically, Return on Equity has averaged 0.5% across 5 years, with a median of 0.44% in 2023.
  • Biggest five-year swings in Return on Equity: tumbled -36bps in 2024 and later skyrocketed 47bps in 2025.
  • Year by year, Return on Equity stood at 0.33% in 2021, then dropped by -27bps to 0.42% in 2022, then plummeted by -60bps to 0.67% in 2023, then dropped by -11bps to 0.75% in 2024, then soared by 62bps to 0.28% in 2025.
  • Business Quant data shows Return on Equity for ADPT at 0.28% in Q4 2025, 0.41% in Q3 2025, and 0.66% in Q2 2025.